Assignee
ONECUREGEN CO LTD
KR·1 granted patent·2 pending applications·0 citations·filing 2020–2022
Top patents by PatentIndex Score
3 records- 0145US2024336659A1Cell-penetrating peptide, anti-cancer peptide, and pharmaceutical composition for preventing or treating cancer, comprising sameONECUREGEN CO LTD·Filed 2022·Application pending·0 cites
- 0242US12534436B2Disubstituted adamantyl derivative or pharmaceutically acceptable salt thereof, and pharmaceutical composition for suppressing cancer growth comprising same as active ingredientONECUREGEN CO LTD·Filed 2020·Granted Jan 27, 2026·0 cites·14 claims
- 0341US2024376165A1Composition comprising vgll1 peptide for treatment of cancerONECUREGEN CO LTD·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →